Our Cancer Profiler Pipeline

GeneCentric's Growing Portfolio of Cancer Profilers

By applying Cancer Subtyping with the rT(I)ME Explorer Platform to specific types of cancer and target biology, GeneCentric has developed and is expanding on its’ portfolio of universal cancer subtypes/biomarkers – what we call ‘Profilers’ – for some of most prevalent and complex cancers and areas of target biology. This growing pipeline is actively leveraged for ongoing studies aimed at deriving drug predictive response signatures. Many tumor types share common molecular subtypes, allowing GeneCentric to leverage these characteristic subtypes to identify candidate responder populations across indications.  The pipeline continues to expand across tumor types.

Cancer Profilers Key

Current

Coming Soon

Future

Cancer Profilers Key

Current

Coming Soon

Future